Diabetes is a chronic condition characterized by hyperglycemia and the seventh leading cause of death in the United States. A CGM device can improve glycemic management and reduce the incidence of hypoglycemia.
At the completion of this knowledg-based activity, the participant will be able to:
- Describe how continuous glucose monitoring (CGM) can improve outcomes for people with diabetes.
- Compare and contrast CGM devices available for personal and professional use.
- Provide appropriate patient education on CGM devices.
- Analyze CGM reports to create personcentered recommendations to achieve glucose targets.
Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-183-H01-P.
To obtain credit for The Pharmacist's Role in Continuous Glucose Monitoring, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: May 1, 2020
Expiration date: May 1, 2023
The Pharmacist's Role in Continuous Glucose Monitoring is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, declares that she is a consultant for Novo Nordisk, Dexcom, and Companion Medical.
Nicholas P. Lehman, PharmD, BCACP, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-183-H01-P||0.2 CEUs||May 01, 2020 - May 01, 2023|